Intravascular Large B-cell Lymphoma Diagnosed by Renal Biopsy Presenting with Nephrotic Syndrome

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/a22f4186d1f6bcf33141761afc7eabe1.pdf
Intravascular Large B-cell Lymphoma Diagnosed by Renal Biopsy Presenting with Nephrotic Syndrome

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Takuya
Kanno
Takuya Kanno kantakutiida@gmail.com Yokohama City University Graduate School of Medicine Department of Medical Science and Cardiorenal Medicine Yokohama Japan *
Shunichiro Tsukamoto tsukamoto.shu.mh@yokohama-cu.ac.jp Yokohama City University Graduate School of Medicine Department of Medical Science and Cardiorenal Medicine Yokohama Japan -
Takayuki Sakuma t_sakuma@yokohama-cu.ac.jp Yokohama City University Graduate School of Medicine Department of Stem Cell and Immune Regulation Yokohama Japan -
Naohiro Nosho nosho.nao.lg@yokohama-cu.ac.jp Yokohama City University Graduate School of Medicine Department of Medical Science and Cardiorenal Medicine Yokohama Japan -
Ayaka Kamio kamio.aya.yh@yokohama-cu.ac.jp Yokohama City University Graduate School of Medicine Department of Medical Science and Cardiorenal Medicine Yokohama Japan -
Ryu Kobayashi ryukoba@yokohama-cu.ac.jp Yokohama City University Graduate School of Medicine Department of Medical Science and Cardiorenal Medicine Yokohama Japan -
Kengo Azushima azushima@yokohama-cu.ac.jp Yokohama City University Graduate School of Medicine Department of Medical Science and Cardiorenal Medicine Yokohama Japan -
Hiromichi Wakui hiro1234@yokohama-cu.ac.jp Yokohama City University Graduate School of Medicine Department of Medical Science and Cardiorenal Medicine Yokohama Japan -
Takahiro Ishiyama ishiyama.tak.ax@yokohama-cu.ac.jp Yokohama City University Graduate School of Medicine Department of Molecular Pathology Yokohama Japan -
Shoji Yamanaka shojiy@yokohama-cu.ac.jp Yokohama City University Hospital Department of Pathology Yokohama Japan -
Satoshi Fujii sfujii@yokohama-cu.ac.jp Yokohama City University Graduate School of Medicine Department of Molecular Pathology Yokohama Japan -
Kouichi Tamura tamukou@yokohama-cu.ac.jp Yokohama City University Graduate School of Medicine Department of Medical Science and Cardiorenal Medicine Yokohama Japan -